[1]许昱,陶泽璋.重视变应性鼻炎药物治疗的规范化和个体化[J].山东大学耳鼻喉眼学报,2017,31(03):4-8.
[2]Bisgaard H,Skoner D.Boza ML.et al.Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-labe l extensionsJ.Pediatr Pulmonol 2009.44 (6):568-579
[3]Allen DB, Meltzer EO,Jr LR,et al.No growth suppression in children treated with the maximum recommended dose of fluticasone prop ionate aqueous nasal spray for one year[J].Allergy Asthma Proc,2002,23 (6):407-413.
[4]Schenkel EJ,Skoner DP,Bronsky EA, et alAbsence of growth retardation in children with perennial allergic rhinitis after one year of ti eatment with mometasonefuroate aqueous nasal spray[J].Pediatrics,2000,105 (2) :E22
[5]Bousquet J,Khaltaev N.Cruz AA.et al.Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization,GA (2) LEN and Aller Gen) [J].Allergy,2008.63 (Suppl86):8-160
[6]李全生,魏庆宇.变应性鼻炎临床实践指南:美国耳鼻咽喉头颈外科学会推荐[J].中国耳鼻咽喉头颈外科,2015,22(09):482-486.
[7]氯化钠注射液(灭菌生理盐水) 宋善俊.临床医师手册 药剂科分册[M]. 1991